Cargando…

Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhargava, Ajay, Anant, Madan, Mack, Hildegard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2016
Materias:	Human Biology and Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769162/ https://www.ncbi.nlm.nih.gov/pubmed/26885666 http://dx.doi.org/10.7554/eLife.11999

Ejemplares similares

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
por: Heidorn, Sonja J., et al.
Publicado: (2010)

Oncogenic RAS drives the CRAF‐dependent extracellular vesicle uptake mechanism coupled with metastasis
por: Choi, Dongsic, et al.
Publicado: (2021)

Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
por: Chatelle, Claire V., et al.
Publicado: (2016)

Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
por: Luan, Zhou, et al.
Publicado: (2014)

Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
por: Advani, Sunil J., et al.
Publicado: (2015)

CRAF R391W is a melanoma driver oncogene
por: Atefi, Mohammad, et al.
Publicado: (2016)

She is dead
por: Rousseau, Paul C.
Publicado: (2021)

Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
por: Jaiswal, Bijay S., et al.
Publicado: (2009)

MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes
por: Taylor, E, et al.
Publicado: (2017)

Three distinct regions of cRaf kinase domain interact with membrane
por: Prakash, Priyanka, et al.
Publicado: (2019)

Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
por: Bhargava, Ajay, et al.
Publicado: (2016)

A CRAF/glutathione-S-transferase P1 complex sustains autocrine growth of cancers with KRAS and BRAF mutations
por: Niitsu, Yoshiro, et al.
Publicado: (2020)

Selective CRAF Inhibition Elicits Transactivation
por: Morgan, Charles W., et al.
Publicado: (2021)

Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report
por: Holland, Roy, et al.
Publicado: (2022)

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
por: Noeparast, Amir, et al.
Publicado: (2019)

PRG3 induces Ras-dependent oncogenic cooperation in gliomas
por: Fan, Zheng, et al.
Publicado: (2016)

The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
por: Shetty, Omshree, et al.
Publicado: (2022)

BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications
por: Oikonomou, Eftychia, et al.
Publicado: (2014)

BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
por: Najafov, Ayaz, et al.
Publicado: (2018)

A MEK-independent role for CRAF in mitosis and tumor progression
por: Mielgo, Ainhoa, et al.
Publicado: (2011)

Cooperative loss of RAS feedback regulation drives myeloid leukemognesis
por: Zhao, Zhen, et al.
Publicado: (2015)

Misshapen Disruption Cooperates with Ras(V12) to Drive Tumorigenesis
por: Kong, Du, et al.
Publicado: (2021)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes
por: Singhal, Ruchi, et al.
Publicado: (2012)

Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
por: Ahmad, I, et al.
Publicado: (2011)

Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis
por: Zhang, F, et al.
Publicado: (2018)

Loss of Phd2 cooperates with BRAF(V600E) to drive melanomagenesis
por: Liu, Shujing, et al.
Publicado: (2018)

Impaired neuronal maturation of hippocampal neural progenitor cells in mice lacking CRAF
por: Pfeiffer, Verena, et al.
Publicado: (2018)

Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling
por: Wu, Jianguo, et al.
Publicado: (2016)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis
por: Leach, Joshua D. G., et al.
Publicado: (2021)

Resilience in Health Care: Surviving a Coinciding Pandemic, a Major Deadly Disaster, and an Economic Collapse: What Did We Learn?
por: Mitri, Maria, et al.
Publicado: (2021)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis
por: Chang, Zhe, et al.
Publicado: (2014)

Temporal Structure in Haptic Signaling Under a Cooperative Task
por: Thorne, Nicolas, et al.
Publicado: (2019)

Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C
Publicado: (1991)

Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
por: Bettoun, Audrey, et al.
Publicado: (2016)

Author Correction: Loss of Phd2 cooperates with BRAF(V600E) to drive melanomagenesis
por: Liu, Shujing, et al.
Publicado: (2019)

BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling
por: Vin, Harina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_odr1ga4s7vau31b6fm6u7s70qr